These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38367145)

  • 1. The relationship between advanced liver fibrosis and osteoporosis in type 2 diabetes patients with MAFLD.
    Pan B; Zhao Y; Chen C; Cai J; Li K; Wang Y; Liu J
    Endocrine; 2024 Jul; 85(1):206-221. PubMed ID: 38367145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients.
    Zhang W; Li Y; Li S; Zhou J; Wang K; Li Z; Chen N; Chen X
    Front Endocrinol (Lausanne); 2023; 14():1278505. PubMed ID: 38116314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation.
    Zhu X; Yan H; Chang X; Xia M; Zhang L; Wang L; Sun X; Yang X; Gao X; Bian H
    BMJ Open Diabetes Res Care; 2020 Aug; 8(1):. PubMed ID: 32759166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between bone mineral density and type 2 diabetes mellitus in elderly men and postmenopausal women.
    Luo W; Li X; Zhou Y; Xu D; Qiao Y
    Sci Rep; 2024 Jul; 14(1):15078. PubMed ID: 38956260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of geriatric nutritional risk index with bone mineral density and osteoporosis in postmenopausal elderly women with T2DM.
    Zhao Y; Chen C; Lv X; Li K; Wang Y; Ma D; Zan X; Han M; Guo X; Fu S; Liu J
    Asia Pac J Clin Nutr; 2024 Sep; 33(3):437-446. PubMed ID: 38965731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Stiffness With Bone Mineral Density in American Adults.
    Li H; Luo H; Zhang Y; Liu L; Lin R
    Front Endocrinol (Lausanne); 2022; 13():891382. PubMed ID: 35846319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017-2018.
    Liu J; Tang Y; Feng Z; Chen Y; Zhang X; Xia Y; Geng B
    Osteoporos Int; 2023 Apr; 34(4):713-724. PubMed ID: 36719471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of concomitant hepatitis C virus infection on liver and cardiovascular risks in patients with metabolic-associated fatty liver disease.
    Tsai PS; Cheng YM; Wang CC; Kao JH
    Eur J Gastroenterol Hepatol; 2023 Nov; 35(11):1278-1283. PubMed ID: 37773778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies.
    Zeng L; Li Y; Hong C; Wang J; Zhu H; Li Q; Cui H; Ma P; Li R; He J; Zhu H; Liu L; Xiao L
    Osteoporos Int; 2024 Apr; 35(4):679-689. PubMed ID: 38221591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between thyroid function, sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects with newly diagnosed type 2 diabetes.
    Zhang X; Chen Y; Ye H; Luo Z; Li J; Chen Z; Zhang E; Li W
    Endocrine; 2023 May; 80(2):366-379. PubMed ID: 36539681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus.
    Shan PF; Wu XP; Zhang H; Cao XZ; Yuan LQ; Liao EY
    J Endocrinol Invest; 2011 Mar; 34(3):190-6. PubMed ID: 20808073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Correlation Analysis Between Adult Hepatic Fibrosis and Bone Mineral Density of the Lumbar Spine and Hip.
    Chen C; Zhang R; Ren C; Wang Y
    Altern Ther Health Med; 2024 Jan; 30(1):172-178. PubMed ID: 37773670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease.
    Fan H; Li L; Liu Z; Zhang P; Wu S; Han X; Chen X; Suo C; Cao L; Zhang T
    BMC Gastroenterol; 2023 Jan; 23(1):3. PubMed ID: 36604612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. J-Shaped Relationship Between Serum Prolactin and Metabolic-Associated Fatty Liver Disease in Female Patients With Type 2 Diabetes.
    Zhu C; Ma H; Huang D; Li G; Gao J; Cai M; You H; Bu L; Qu S
    Front Endocrinol (Lausanne); 2022; 13():815995. PubMed ID: 35222274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
    Kim G; Kim KJ; Rhee Y; Lim SK
    PLoS One; 2017; 12(7):e0182202. PubMed ID: 28759632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients: what do we know so far ?
    Binet Q; Loumaye A; Preumont V; Thissen JP; Hermans MP; Lanthier N
    Acta Gastroenterol Belg; 2022; 85(2):346-357. PubMed ID: 35709779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Irisin is Associated with Bone Mineral Density in Postmenopausal T2dm Patients Complicated with Osteoporosis and in Mice with Diabetic Osteoporosis.
    Hou X; Xing B; Zhang G; Wu H; Feng N; Li Y; Han G
    Curr Protein Pept Sci; 2023; 24(4):355-363. PubMed ID: 36852814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A positive correlation between blood glucose level and bone mineral density in Taiwan.
    Li KH; Liu YT; Yang YW; Lin YL; Hung ML; Lin IC
    Arch Osteoporos; 2018 Jul; 13(1):78. PubMed ID: 30009330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction-associated fatty liver disease in Korea.
    Kim M; Yoon EL; Cho S; Lee CM; Kang BK; Park H; Jun DW; Nah EH
    Liver Int; 2022 Jul; 42(7):1536-1544. PubMed ID: 35338555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum isthmin-1 is a potential biomarker for metabolic dysfunction associated fatty liver disease in patients with metabolic syndrome and type 2 diabetes mellitus.
    Lei X; Chen H; Xu Y; Yang Z; Zhang L; Wang C; Du H
    BMJ Open Diabetes Res Care; 2024 Sep; 12(5):. PubMed ID: 39322582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.